Hippocratic AI

Hippocratic AI develops safety-focused generative AI healthcare agents, including voice agents, for non-diagnostic patient-facing tasks like follow-up, education, chronic-care check-ins, and documentation support, plus a Nurse Co-Pilot. It sells to health systems and payers, emphasizes nurse empowerment, and has raised over $400M at a $3.5B valuation. Deployments run under HIPAA with human escalation and clinical oversight.

Hippocratic AI builds generative AI 'healthcare agents' designed for non-diagnostic, patient-facing work such as pre-op and post-discharge follow-up, chronic-care check-ins, medication reminders, patient education, and administrative support. The company emphasizes safety and, deliberately, positions its agents away from diagnosis and clinical decision-making, focusing instead on tasks where conversational AI can extend care-team capacity. It has also introduced a Nurse Co-Pilot that embeds in the EHR to offload bedside documentation and education, and an agent 'app store' model. A central theme is nurse empowerment and outcome-oriented deployment: Hippocratic frames its agents as augmenting clinicians rather than replacing them, and it has partnered with nursing organizations on research initiatives. Pricing has been discussed publicly around a per-agent-hour model, but concrete terms are enterprise-negotiated with health systems and payers. The company reached unicorn status and, as of its Series C, had raised over $400 million at a reported $3.5 billion valuation, with investors including major growth funds and strategic health-system backers. As with all patient-facing healthcare AI, deployments occur under HIPAA and clinical-governance oversight, and the safety of voice agents interacting with patients depends heavily on guardrails, escalation to humans, and rigorous validation. Hippocratic markets extensive safety testing, but buyers should independently assess clinical risk, escalation design, and outcomes.